11 documents found, page 1 of 2
EUFOREA/EPOS2020 statement on the clinical considerations for CRSwNP care
Hellings, Peter; Alobid, Isam; Anselmo‐Lima, Wilma T.; Bernal‐Sprekelsen, Manuel; Bjermer, Leif; Caulley, Lisa; Chaker, Adam; Constantinidis, JannisFollowing the European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA) treatment algorithm for chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP), patients suffering from severe uncontrolled CRSwNP are recommended to receive oral corticosteroids, (revision) sinus surgery, systemic biologicals and/or aspirin treatment after desensitization (ATAD). Given the major differences in ind...
Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines fo...
Bousquet, Jean; Schünemann, Holger J; Togias, Akdis; Bachert, Claus; Erhola, Martina; Hellings, Peter; Klimek, Ludger; Pfaar, Oliver; Wallace, DanaThe selection of pharmacotherapy for patients with allergic rhinitis aims to control the disease and depends on many factors. Grading of Recommendations Assessment, Development and Evaluation (GRADE) guidelines have considerably improved the treatment of allergic rhinitis. However, there is an increasing trend toward use of real-world evidence to inform clinical practice, especially because randomized controlle...
European Position Paper on Rhinosinusitis and Nasal Polyps 2020
Fokkens, W.J.; Lund, V.J.; Hopkins, C.; Hellings, Peter; Kern, R.; Reitsma, S.; Toppila-Salmi, S.; Bernal-Sprekelsen, M.; Mullol, J.; Alobid, I.The European Position Paper on Rhinosinusitis and Nasal Polyps 2020 is the update of similar evidence based position papers published in 2005 and 2007 and 2012. The core objective of the EPOS2020 guideline is to provide revised, up-to-date and clear evidence-based recommendations and integrated care pathways in ARS and CRS. EPOS2020 provides an update on the literature published and studies undertaken in the ei...
ARIA pharmacy 2018: Allergic rhinitis care pathways for community pharmacy
Bosnic-Anticevich, Sinthia; Costa, Elísio; Menditto, Enrica; Lourenço, Olga; Novellino, Ettore; Bialek, Slawomir; Briedis, Vitalis; Buonaiuto, RolandPharmacists are trusted health care professionals. Many patients use over-the-counter (OTC) medications and are seen by pharmacists who are the initial point of contact for allergic rhinitis management in most countries. The role of pharmacists in integrated care pathways (ICPs) for allergic diseases is important. This paper builds on existing studies and provides tools intended to help pharmacists provide opti...
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change manage...
Bousquet, Jean; Hellings, Peter; Agache, Ioana; Amat, Flore; Annesi-Maesano, Isabella; Ansotegui, Ignacio J; Anto, Josep M; Bachert, ClausAllergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline by using the best approach to integrated care pathways using mobile technology in patients with allergic rhinitis (AR) and asthma multimorbidity. The proposed next phase of ARIA is change management, with the aim of providing an active and healthy life to patients with rhinitis and to those with asthma multimorbidity across the lifec...
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-cent...
Bousquet, Jean; Bedbrook, Anna; Czarlewski, W; Onorato, G L; Arnavielhe, S; Laune, Daniel; Mathieu-Dupas, Eve; Fonseca, J; Costa, E; Lourenço, OlgaAims: Mobile Airways Sentinel NetworK (MASK) belongs to the Fondation Partenariale MACVIA-LR of Montpellier, France and aims to provide an active and healthy life to rhinitis sufferers and to those with asthma multimorbidity across the life cycle, whatever their gender or socio-economic status, in order to reduce health and social inequities incurred by the disease and to improve the digital transformation of h...
Next-generation ARIA care pathways for rhinitis and asthma: a model for multimo...
Bousquet, Jean; Schünemann, Holger; Togias, Alkis; Erhola, Marina; Hellings, Peter; Zuberbier, Torsten; Agache, IoanaBackground: In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system into integrated care with organizational health literacy. Main body: As an example for chronic disease care, MASK (Mobile Airways Sentinel NetworK), a...
Mobile Technology in Allergic Rhinitis: Evolution in Management or Revolution i...
Bousquet, Jean; Ansotegui, Ignacio J; Anto, Josep M.; Arnavielhe, Sylvie; Bachert, Claus; Basagaña, Xavier; Bédard, Annabelle; Bedbrook, AnnaSmart devices and Internet-based applications (apps) are largely used in allergic rhinitis and may help to address some unmet needs. However, these new tools need to first of all be tested for privacy rules, acceptability, usability, and cost-effectiveness. Second, they should be evaluated in the frame of the digital transformation of health, their impact on health care delivery, and health outcomes. This revie...
EPOS2020: development strategy and goals for the latest European Position Paper...
Fokkens, W; Desrosiers, M; Harvey, R; Hopkins, C; Mullol, J; Philpott, C; Alobid, I; Lima, W T Anselmo; Bachert, Claus; Baroody, F; Bernal-Sprekelsen, MBackground: The European Position Papers on Rhinosinusitis from 2005, 2007 and 2012 have had a measurable impact on the way this common condition with high impact on quality of life is managed around the world. EPOS2020 will be the latest iteration of the guideline, addressing new stakeholders and target users, presenting a summary of the latest literature and evolving treatment modalities, and formulating clea...
2019 ARIA Care pathways for allergen immunotherapy
Bousquet, Jean; Pfaar, Oliver; Togias, Alkis; Schünemann, Holger J; Ansotegui, Ignacio; Papadopoulos, Nikolaos G; Tsiligianni, Ioanna; Agache, IoanaAllergen immunotherapy (AIT) is a proven therapeutic option for the treatment of allergic rhinitis and/or asthma. Many guidelines or national practice guidelines have been produced but the evidence-based method varies, many are complex and none propose care pathways. This paper reviews care pathways for AIT using strict criteria and provides simple recommendations that can be used by all stakeholders including ...